Omada Health, Inc.
OMDA
$12.61
$0.040.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 58.08% | 49.47% | 48.92% | 56.61% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 58.08% | 49.47% | 48.92% | 56.61% | |
| Cost of Revenue | 40.01% | 35.43% | 28.62% | 29.95% | |
| Gross Profit | 67.00% | 57.80% | 62.30% | 83.88% | |
| SG&A Expenses | 29.24% | 32.04% | 33.77% | 19.08% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 31.75% | 30.54% | 28.23% | 19.35% | |
| Operating Income | 146.21% | 70.52% | 56.72% | 53.34% | |
| Income Before Tax | 162.53% | 65.55% | 50.33% | 50.19% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 162.53% | 65.55% | 50.33% | 50.19% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 162.53% | 65.55% | 50.33% | 50.19% | |
| EBIT | 146.21% | 70.52% | 56.72% | 53.34% | |
| EBITDA | 181.21% | 84.18% | 66.25% | 58.13% | |
| EPS Basic | 108.57% | 95.35% | 82.71% | 54.71% | |
| Normalized Basic EPS | 108.56% | 98.43% | 82.70% | 54.71% | |
| EPS Diluted | 107.78% | 95.35% | 82.71% | 54.71% | |
| Normalized Diluted EPS | 107.77% | 98.43% | 82.70% | 54.71% | |
| Average Basic Shares Outstanding | 630.08% | 640.34% | 187.24% | 9.98% | |
| Average Diluted Shares Outstanding | 703.95% | 640.34% | 187.24% | 9.98% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |